Oncology

Top news of the day from across the healthcare landscape.

Organ recipients with a history of cancer were 1.5 times more likely to die early from any cause compared with organ recipients without history of cancer.

Opdivo shows overall survival benefit at the 2-year time point compared with docetaxel in advanced non-small cell lung cancer.

Treatment approach may eradicate triple-negative breast cancer.

Use of statins may lower the risk of prostate cancer associated with high fat intake.

Granulin implicated in the spread of cancer from the pancreas to the liver.

Top news of the day from across the health care landscape.

Chimeric antigen receptor (CAR) T-cell therapy has generated a lot of buzz in the drug development world.

Keytruda is a humanized monoclonal antibody that increases the ability of the immune system to detect and fight tumor cells.

The biological mechanisms underlying the association between a successful plasma analysis and the age of non-small cell lung cancer patients are not fully understood.

HPV vaccine found effective in reducing related cancers across all races and ethnic groups.

Top news of the day from across the health care landscape.

Lack of enrollment in clinical trials hinder advancement of cancer therapy.

Cancer diagnosis may potentially cause a decrease in physical function and mental health.

Treatment of elderly patients with multiple myeloma creates unique hurdles for care providers.

Cisplatin kills both rapidly dividing cells and non-dividing cells in the inner ear, which can lead to hearing loss.

Cancer drugs that inhibit class 1 histone deacetylases may reduce excess enlargement of heart muscle cells.

Patients with chronic hepatitis C virus have an increased risk of developing B-cell lymphomas.

Patients with chronic hepatitis C virus have an increased risk of developing B-cell lymphomas.

Sharing genetic and clinical information from cancer patients could allow researchers to better personalize cancer treatments.

Compound in horseradish called glucosinolates found to eliminate cancer-causing free radicals.

Recent advances and updates in oncology and cancer drug development.

Study finds medication reconciliation reduces error incidence in cancer patients undergoing chemotherapy.

Epigenetic changes can leave cancer stem cells vulnerable to a combination of 5-azacytidine and butyrate.

Researchers examine the relationship between sleep disorders and melanoma.

Various approaches needed for immunotherapy efficacy to translate into significant real world outcomes.

Alecensa found superior to crizotinib in advanced or recurrent, ALK-positive non-small cell lung cancer.

Targaprimir-96 causes programmed cell death in breast cancer animal models.